Revision history of "Shortcourse light then mFOLFOX6 in addition avelumab with regard to locallyadvanced rectal adenocarcinoma"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 10:03, 18 May 2024Visionnoise41 (Talk | contribs). . (3,337 bytes) (+3,337). . (Created page with "8% as opposed to 56.4%). When they decided WAVR, they had better anxiolysis (79% compared to 47%, Equals 0.01)' and improved entertainment (90% versus 59%, Equates to 0.005)....")